Literature DB >> 20419821

Detection of viral DNA sequences in the cerebrospinal fluid of patients with multiple sclerosis.

Roberta Mancuso1, Ambra Hernis, Rosella Cavarretta, Domenico Caputo, Elena Calabrese, Raffaello Nemni, Pasquale Ferrante, Serena Delbue, Mario Clerici.   

Abstract

The role of viruses in the pathogenesis of multiple sclerosis (MS) is a subject of heated debate. The presence of six different neurotropic viruses was sought, including JC virus (JCV), varicella zoster virus (VZV), human herpesvirus 6 (HHV-6), and Epstein-Barr virus (EBV), in cerebrospinal fluid (CSF) samples collected from 51 patients with MS and 30 patients with other neurological diseases. Cell-free or cell-associated viral DNA in CSF samples was detected by real-time PCR, and viral loads were determined. Magnetic resonance imaging (MRI) examinations were also performed to look for active lesions. Cell-associated JCV DNA was detected in 3 of the 51 patients with MS and in 2 of the 30 patients with other neurological disease. Cell-free JCV DNA was detected in one additional patient with MS. Cell-free VZV DNA was detected in one patient without MS, cell-free HHV-6 was detected in one patient with MS, and cell-free EBV was detected in one patient with MS. All other study patients had no detectable viral DNA in CSF samples and no double infections were found. The small percentage of patients with detectable viral DNA in CSF samples was comparable between patients with MS and those with other neurological disease, and presence of viral DNA was not a predictor of brain lesions. Additional observations suggest that cell trafficking from the periphery, rather than leakage through the blood-brain barrier, results in the transport of viruses to the CNS, where local immunosurveillance can control viral replication in immunocompetent individuals. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419821     DOI: 10.1002/jmv.21764

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

Review 1.  Nucleic acids in circulation: are they harmful to the host?

Authors:  Indraneel Mittra; Naveen Kumar Nair; Pradyumna Kumar Mishra
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

2.  Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.

Authors:  Maria Teresa Ferrò; Diego Franciotta; Alessandro Prelle; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2012-05-19       Impact factor: 2.643

3.  Detection of varicella-zoster virus DNA during medullary and brainstem relapses in multiple sclerosis.

Authors:  Øivind Torkildsen; Øystein Power; Anette Storstein
Journal:  BMJ Case Rep       Date:  2016-02-23

Review 4.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

5.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

Review 6.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 7.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

8.  Real-time PCR detection of human herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection.

Authors:  Birgitta Sundén; Marie Larsson; Tina Falkeborn; Jakob Paues; Urban Forsum; Magnus Lindh; Liselotte Ydrenius; Britt Akerlind; Lena Serrander
Journal:  BMC Infect Dis       Date:  2011-08-17       Impact factor: 3.090

Review 9.  B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.

Authors:  Maria T Cencioni; Miriam Mattoscio; Roberta Magliozzi; Amit Bar-Or; Paolo A Muraro
Journal:  Nat Rev Neurol       Date:  2021-06-01       Impact factor: 42.937

10.  DNA methylation as clinically useful biomarkers-light at the end of the tunnel.

Authors:  Victor V Levenson; Anatoliy A Melnikov
Journal:  Pharmaceuticals (Basel)       Date:  2012-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.